Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-07-17FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for WELLBUTRIN SR (bupropion hydrochloride) from GlaxoSmithKline, updating the labeling through a su…
-
FDA approval · 2014-07-17FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Citalopram Hydrobromide from Aurobindo Pharma Limited, authorizing the generic product for U…
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2014-07-17FDA Approved: DOXEPIN HYDROCHLORIDE — Supplemental Application (Endo USA, Inc.)
FDA approved Endo USA, Inc.'s supplemental application for doxepin hydrochloride, updating the previously approved abbreviated new drug appl…
-
FDA label_change · 2014-07-17FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for trazodone hydrochloride from Sun Pharmaceutical Industries, resulting in changes to the drug…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-07-17FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for the PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE product from Mylan Pharmaceuticals Inc., in…
-
FDA approval · 2014-07-17FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Amitriptyline Hydrochloride from Aurobindo Pharma Limited, confirming regulatory approval of thi…
-
FDA approval · 2014-07-17FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for AMITRIPTYLINE HYDROCHLORIDE (Sandoz Inc) under an ANDA, authorizing changes to the approved gene…
-
FDA approval · 2014-07-17FDA Approved: NEFAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for NEFAZODONE HYDROCHLORIDE from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2014-07-17FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved the supplemental application to approve Pristiq Extended-Release (desvenlafaxine succinate) from Wyeth/Pfizer.
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride (generic) from Dr. Reddy's Laboratories Limited. This action approves …
-
FDA approval · 2014-07-17FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for imipramine hydrochloride by Lupin Pharmaceuticals, confirming continued approval for the generic…
-
FDA approval · 2014-07-17FDA Approved: AMOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Amoxapine from Actavis Pharma, Inc., under an ANDA, expanding/sending forward the approval statu…
-
FDA approval · 2014-07-17FDA Approved: PHENELZINE SULFATE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Phenelzine sulfate (ANDA 200181), a generic monoamine oxidase inhibitor use…
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved Alembic Pharmaceuticals' supplemental application for a generic venlafaxine product (ANDA 078932). Venlafaxine is indicated…
-
FDA approval · 2014-07-17FDA Approved: AMOXAPINE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for amoxapine from Chartwell RX, LLC, updating the labeling for this generic antidepressant.
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: Antiglucocorticoid Augmentation of antiDepressants in Depression [Phase 3]
A Phase 3 clinical trial investigating antiglucocorticoid augmentation of antidepressants for depression has completed.
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride, a generic venlafaxine product from Aurobindo Pharma Limited.
-
FDA approval · 2014-07-17FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved the supplemental application for Fluoxetine from Aurobindo Pharma Limited, indicating continued approval of this generic produc…
-
FDA approval · 2014-07-16FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for VIIBRYD (vilazodone hydrochloride) submitted by Allergan, Inc.
-
FDA approval · 2014-07-16FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for a generic fluoxetine hydrochloride product from Lannett Company, Inc. The approval authorize…
-
CLINICAL_TRIALS withdrawal · 2014-07-16Clinical Trial Update: Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients [Phase 4]
Phase 4 trial evaluating paroxetine controlled-release for major depressive disorder in irritable bowel syndrome patients was withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled Trial [Phase 4]
This document reports an update on a randomized controlled trial evaluating measurement-based care for adults with major depressive disorder…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Evaluation of a Natural Experiment to Improve Statewide Depression Care in Minnesota (MN) [NA]
A completed evaluation of a natural experiment aimed at improving statewide depression care in Minnesota.
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Investigational Study of Psychological Intervention in Recipients of Lung Transplant (INSPIRE) [NA]
Completed clinical trial evaluating a psychological intervention in recipients of lung transplants. The study addressed conditions of lung d…